The interplay between MYC and HIF in the Warburg effect

Area of Science:

• Oncology
• Molecular Biology
• Cancer Metabolism

Background:

• c-MYC drives cell proliferation and metabolism, while hypoxia-inducible factors (HIFs) aid adaptation to low-oxygen environments.
• In tumors, MYC and HIF (particularly HIF-1) cooperate to meet increased metabolic demands via enhanced glucose uptake and lactate production.

Purpose of the Study:

• To investigate the collaborative roles of c-MYC and HIF in cancer metabolism.
• To identify shared target genes of MYC and HIF as potential therapeutic targets.

Main Methods:

• Analysis of gene expression patterns related to MYC and HIF signaling in cancer.
• Examination of metabolic pathways, including glucose uptake, glycolysis, and mitochondrial respiration.
• Identification of common downstream targets of MYC and HIF.

Main Results:

• Oncogenic MYC and elevated HIF levels synergistically increase glucose consumption and lactate production, contributing to the Warburg effect.
• HIF induces pyruvate dehydrogenase kinase 1 (PDK1), which attenuates mitochondrial respiration.
• Shared target genes (PDK1, LDHA, HK2, TFRC) are coordinately regulated by MYC and HIF.

Conclusions:

• The collaboration between MYC and HIF significantly alters cancer cell metabolism.
• Targeting genes commonly induced by MYC and HIF, such as PDK1, presents a viable strategy to widen the therapeutic window in cancer treatment.